XOMA - XOMA Corp
XOMA Corp Logo

XOMA - XOMA Corp

https://www.xoma.com
Strong Sell Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-08 (Snapshot)

XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California.

52W High
$36.32
52W Low
$18.35
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.99
Valuation
Rich
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
26.32
EV/EBITDA (<8 favorable)
54.00
EV/Revenue (<3 favorable)
35.76
P/S (TTM) (<3 favorable)
9.48
P/B (<3 favorable)
4.61
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
0.94%
Institutions (25–75% balanced)
68.01%
Shares Outstanding
12,087,700
Float
9,356,900
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
2025-01-03
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
44,952,000
Gross Profit (TTM)
41,909,000
EPS (TTM)
-1.42
Profit Margin (>10% good)
-0.22%
Operating Margin (TTM) (higher better)
0.35%
ROE (TTM) (>15% strong)
-0.10%
EPS YoY (Quarterly) (>10% good)
-0.48
Revenue YoY (Quarterly) (>8% good)
0.18
Momentum
Bearish momentum
Value
2.5272
Previous
2.5073
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025